• Hold responsibility for the execution of the scientific plan• Lead the regulatory infrastructure related to research finance, research integrity and protocol governance• Partner with the Executive team to support engagement, and development• Promote the collaboration between KOL of pre-clinical, clinical and basic science research programs with Executive and R&D teams• Coordinate with R&D team to ensure efficient and effective operations between lab and Executive Team• Oversee and directs budget management for scientific research programs and allocation of resources• Oversee the overall operation and integration of scientific cores• Manage budget and timeline commitments for R&D team• Lead preparation of regulatory submission documents• Manage internal team to meet discovery milestones• Ensure a scientifically and independent rigorous review of the company’s projects at initiation and throughout their course and ongoing improvement and refinement of processes for the scientific evaluation of projects• Present the company’s projects to potential investors

• Conducts site monitoring responsibilities for Clinical trials, according to Covance Standard Operating Procedures, ICH guidelines and GCP, including Pre-study, Site Initiation, Routine Monitoring and Close-out Visits• Assists with the implementation of Project Plans relate to the Clinical Monitoring responsibilities• Ensures the protection of subjects by verifying that informed consent procedures and protocol requirements are adhered to according to the applicable regulatory requirements• Ensures data integrity by careful source document review, query generation and resolution against established data review guidelines on Covance or client data management systems• Ensures Site Regulatory Documents are complete and current throughout the duration of the trial• Ensures that the study compound inventory and accountability is accurate and that study materials are stored securely and per protocol requirements

• Manage and Coordinate 12 pharma sponsored Oncology/hematology clinical trials (Phase I-III: Roche, BMS, Onyx, Genentech, Array) in accordance to Knowledge of Good Clinical Practices and ICH standards• Manage clinical trials and assign tasks and protocol specific procedures to a team of medical doctors and nurses• Manage 2 data entry personnel to efficiently update and maintain data in the Clinical Data Capturing systems• Responsible for the recruitment of subjects and achieves target number• Maintain subject schedule and trial related visits• Meet with CRAs and Sponsors to review source documents, patient charts, eCRFs and queries• Attend Investigator Meetings, Tumor board meetings• Train MD’s and staff on trial specific delegation tasks• Responsible for entering data in eCRF and answer queries• Implemented new eCalendar system in the Unit to efficiently coordinate scheduled visits with patients, nurses, MD’s and coordinators• Implemented new source documents to comply with CRU SOPs• Developed electronic tumor calculator that meets RECIST 1.1 and Cheson criteria

• Collaborated with and was funded by five major pharmaceutical companies (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Pfizer) while working at the Medical Research Council Protein Phosphorylation Unit which plays a major role in drug discovery • Studied the LPS/IL-1/TNFalpha signaling pathways for treatments of various auto-immune disorders for pre-clinical trials (Lupus, rheumatoid arthritis, psoriasis)• Designed animations slides and poster templates for scientific meetings/presentations• Trained and supervised students• Wrote and organized lab research protocols

• Educated representatives of 5 major Pharmaceutical companies (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Pfizer) on pharmacological aspects of protein kinase inhibitors that were used in screening panels related to auto-immune disorders• Presented research progress reports to pharmaceutical companies• Refocused research aspects to meet the demands and needs of Pharmaceutical companies regarding their motivation towards drug target and development